Soligenix
SNGX
$0.42
Share price
-2.81%
Change (1 day)
-71.58%
Change (1 year)
Categories
Soligenix (SNGX) - P/B ratio
P/B ratio as of April 2024 : 2.39
According to Soligenix's latest financial reports the company has a price-to-book ratio of 2.39.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Soligenix - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.12 | -139.4% |
| 2022-12-31 | -7.91 | -399.52% |
| 2021-12-31 | 2.64 | -74.14% |
| 2020-12-31 | 10.2 | -52.83% |
| 2019-12-31 | 21.6 | 793.95% |
| 2018-12-31 | 2.42 | -21.03% |
| 2017-12-31 | 3.07 | 85.44% |
| 2016-12-31 | 1.65 | -100.09% |
| 2015-12-31 | < -1000 | 1166.71% |
| 2014-12-31 | -152 | 663.26% |
| 2013-12-31 | -20.0 | -1157.76% |
| 2012-12-31 | 1.89 | 109.36% |
| 2011-12-31 | 0.9014 | -83.85% |
| 2010-12-31 | 5.58 | -1.68% |
| 2009-12-31 | 5.68 | 83.79% |
| 2008-12-31 | 3.09 | -50.33% |
| 2007-12-31 | 6.22 | -141.77% |
| 2006-12-31 | -14.9 | -266.52% |
| 2005-12-31 | 8.94 | -0.84% |
| 2004-12-31 | 9.02 | 75.08% |
| 2003-12-31 | 5.15 | 118.26% |
| 2002-12-31 | 2.36 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 114.24% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -32.63% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | -37.48% | 🇫🇷 France |
 Onconova Therapeutics ONTX | 1.44 | -39.75% | 🇺🇸 USA |
 Athersys ATHX | -0.0229 | -100.96% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.92 | -19.46% | 🇮🇱 Israel |
 Emergent BioSolutions
EBS | 0.1549 | -93.52% | 🇺🇸 USA |